Behavioral and biochemical effects of subchronic treatment with (?)3-(3-hydroxyphenyl)-N-n-propylpiperidine in the rat: Dopamine receptor sensitivity and tolerance
- 1 June 1984
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 60 (2) , 103-113
- https://doi.org/10.1007/bf01245028
Abstract
Male Sprague-Dawley rats were treated for 3 weeks with (−)3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP). Twenty-four hours, but not 72 hours, after withdrawal of the treatment there was an increase in locomotor activity in comparison with saline treated controls. At the same time there was a decrease in striatal DOPAC and HVA and an increased locomotor activity response to apomorphine, indicating supersensitive dopamine receptors. There was no evidence for behavioral tolerance since the suppression of locomotor activity after an acute dose of (−)3-PPP was the same in (−)3-PPP-pretreated as in saline-treated controls. Plasma levels of (-)3-PPP in these animals were, however, slightly decreased.This publication has 16 references indexed in Scilit:
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomersPsychopharmacology, 1983
- Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPPPsychopharmacology, 1983
- Spontaneous Orofacial Dyskinesia and Dopaminergic Function in Rats After 6 Months of Neuroleptic TreatmentScience, 1983
- A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine)Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1982
- Receptor Adaptations to Centrally Acting DrugsAnnual Review of Pharmacology and Toxicology, 1981
- Supersensitivity of pituitary dopamine receptors involved in the inhibition of prolactin secretion.1980
- BEHAVIOURAL EFFECTS OF ERGOT DRUGSPublished by Elsevier ,1979
- Alteration in the action of cholinergic and anti cholinergic drugs after chronic haloperidol: Indirect evidence for cholinergic hyposensitivityLife Sciences, 1976